Solos Endoscopy, Inc. is a thirty year old medical technology company whose mission is to develop and market breakthrough innovative, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions. When it comes to endoscopy, Solos was a pioneer. Its early work in laparoscopic endoscopy allowed it to become a market leader in the field of surgical endoscopy. Today Solos Endoscopy continues to look for innovative product developments to further expand the company within the growing endoscopic marketplace.
Quote | Solos Endoscopy Inc (OTCMKTS:SNDY)
Last: | $0.0037 |
---|---|
Change Percent: | -2.63% |
Open: | $0.0037 |
Close: | $0.0037 |
High: | $0.0075 |
Low: | $0.0037 |
Volume: | 1,539,651 |
Last Trade Date Time: | 11/30/2020 04:55:52 pm |
News | Solos Endoscopy Inc (OTCMKTS:SNDY)
WESTPORT, CT / ACCESSWIRE / December 02, 2020/ CYduct Diagnostics, Inc. (OTC PINK:SNDYD) is pleased to announce it has signed a Letter of Intent to acquire all the assets of HHC PREFERRED LLC. ("HHC") CYduct Diagnostics, an emerging innovator in the breast healthcare wellness segment of wom...
WESTPORT, CT / ACCESSWIRE / November 30, 2020 / Solos Endoscopy, Inc. (OTC PINK:SNDY) is pleased to announce that as of December 1, 2020, the Company will have effectuated its capital restructuring and will have changed its name to CYduct Diagnostics, Inc. The Board of Directors and majority...
Message Board Posts | Solos Endoscopy Inc (OTCMKTS:SNDY)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
WESTPORT, CT / ACCESSWIRE / December 02, 2020/ CYduct Diagnostics, Inc. (OTC PINK:SNDYD) is pleased to announce it has signed a Letter of Intent to acquire all the assets of HHC PREFERRED LLC. ("HHC") CYduct Diagnostics, an emerging innovator in the breast healthcare wellness segment of wom...
WESTPORT, CT / ACCESSWIRE / November 30, 2020 / Solos Endoscopy, Inc. (OTC PINK:SNDY) is pleased to announce that as of December 1, 2020, the Company will have effectuated its capital restructuring and will have changed its name to CYduct Diagnostics, Inc. The Board of Directors and majority...
WESTPORT, CT / ACCESSWIRE / November 20, 2020 / Solos Endoscopy, Inc. (OTC PINK:SNDY) is pleased to announce that Solos' CEO and majority shareholder, Dominick Gatto, has contributed to Solos the extensive research and intellectual property of CYduct LLC, which he also controls. These assets...